Daewoong Pharm to tender offer 30% of own shares

Daewoong Pharm Co., Korea's leading pharmaceutical manufacturer, plans to tender offer 30 percent of its own common shares in a bid to meet the legal requirement of Fair Trade Code Law on a holding company but the influence on its stock price is negligible, a domestic stock market analyst said.

According to Oh Seung-taik, an analyst at Sejong Securities, Daewoong Pharm will issue its new sha...